Evidence for peripheral release of a lymphokine following transplantation in mice
Korcáková, L.; Paluska, E.
Folia Biologica 27(5): 318-323
1981
ISSN/ISBN: 0015-5500 PMID: 7028524 Document Number: 180313
Mouse sera obtained 14-18 h after transplantation of skin or spleen cells from H-2-disparate donors contain a "lymph node activating factor". They activate the draining lymph nodes of syngeneic recipients or F1 hybrids of the mouse strains, which have served as graft donors and recipients, and give specific precipitation lines with the antibody against LNAF. LNAF can be determined in the sera of mice, which have been sensitized with spleen cells prior to transplantation, from 7 to 48 h after transplantation.
Document emailed within 1 workday
Related Documents
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281Komatsubara, H.; Umeda, M.; Ojima, Y.; Minamikawa, T.; Komori, T. 2005: Detection of cancer cells in the peripheral blood and lung of mice after transplantation of human adenoid cystic carcinoma Kobe Journal of Medical Sciences 51(5-6): 67-72
Capková, J.; Korcáková, L.; Paluska, E.; Hasková, V. 1981: Genetic conditions for the release of a lymphokine "lymph node activating factor" Folia Biologica 27(4): 233-239
Metzner, G.; Franz, H.; Kindt, A.; Schumann, I.; Fahlbusch, B. 1987: Effects of lectin I from mistletoe (ML I) and its isolated A and B chains on human mononuclear cells: mitogenic activity and lymphokine release Die Pharmazie 42(5): 337-340
Silver, R.M. 1990: Lymphokine activated killer (LAK) cell activity in the peripheral blood lymphocytes of systemic sclerosis (SSc) patients Clinical and Experimental Rheumatology 8(5): 481-486
Guillaume, T.; Sekhavat, M.; Rubinstein, D.B.; Hamdan, O.; Leblanc, P.; Symann, M.L. 1994: Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution Cancer Research 54(14): 3800-3807
Kelly, R.H.; Wolstencroft, R.A.; Dumonde, D.C.; Balfour, B.M. 1972: Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation Clinical and Experimental Immunology 10(1): 49-65
Orita, K.; Miwa, H.; Yamashita, H.; Kurimoto, M. 1984: Antitumor effect of new lymphokine OH-1 on BDF1 mice bearing Lewis lung carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(6): 1253-1256
Takahashi, M. 1991: Specific antitumor effect of lymphokine-activated lymphocytes obtained from tumor-bearing mice after intratumoral injection of interleukin-2 (IL-2) Nihon Geka Gakkai Zasshi 92(3): 247-256
Sodhi, S.; Ganguly, N.K.; Malla, N.; Mahajan, R.C. 1989: Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice Japanese Journal of Experimental Medicine 59(3): 103-108
Shiloni, E.; Lafreniere, R.; Mulé, J.J.; Schwarz, S.L.; Rosenberg, S.A. 1986: Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice Cancer Research 46(11): 5633-5640
Landolfo, S.; Giovarelli, M.; Capusso, A.; Forni, G. 1979: Lymphokine production in primary mixed lymphocyte culture (MLC). III. Alloantigen signals cell-cell interactions involved in migration inhibition factor and immune interferon release Bollettino dell'Istituto Sieroterapico Milanese 58(2): 128-132
Fairchild, R.L.; Moorhead, J.W. 1986: Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro Journal of Immunology 137(7): 2125-2131
Ungkanont, A.; Jootar, S.; Chuncharunee, S.; Chaisiripoomkere, W. 1999: Delayed administration of G-CSF in both mobilization and post transplantation in autologous peripheral blood stem cell transplantation Asian Pacific Journal of Allergy and Immunology 17(4): 289-293
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Yamaguchi, A.; Yamadera, H.; Matsuda, M.; Sumimoto, R.; Kamada, N. 1991: Cellular basis of transplantation tolerance induced by rat liver transplantation: evidence for suppressor cell activity in vivo Transplantation Proceedings 23(1 Part 1): 866-867
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Jungerman, M.; Sedzimirska, M.; Lange, A.; Witt, M. 1998: Application of microsatellite markers for monitoring of reconstitution pattern in patients after bone marrow transplantation/peripheral blood progenitor cell transplantation Archivum Immunologiae et Therapiae Experimentalis 46(1): 39-43
Saito, T.; Okadome, M.; Sugihara, K.; Sano, M.; Kamura, T.; Nakano, H. 1994: Antiproliferative lymphokine production by human peripheral blood lymphocytes and lymph node lymphocytes detected by a modified double layer soft agarose clonogenic assay Lymphokine and Cytokine Research 13(1): 55-62
Suit, H.D.; Sedlacek, R.S.; Zietman, A. 1988: Quantitative transplantation assays of spontaneous tumors of the C3H mouse as allografts in athymic NCr/Sed-nu/nu nude mice and isografts in C3Hf/Sed mice Cancer Research 48(16): 4525-4528